Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. Tang W, Cao Z, Han M, Wang Z, et al. BMJ 2020;369:m1849.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang W, Cao Z, Han M, Wang Z, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ 2020;369:m1849.
PMID: 32409561